Cargando…
Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross‐European survey
AIMS: Population data indicate that one in 25 persons of African ancestry has heart failure, a condition with relatively high mortality of around 50% in 5 years. Combined hydralazine and isosorbide dinitrate added to conventional therapy in African ancestry patients with heart failure and reduced ej...
Autor principal: | Brewster, Lizzy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487721/ https://www.ncbi.nlm.nih.gov/pubmed/30892835 http://dx.doi.org/10.1002/ehf2.12421 |
Ejemplares similares
-
Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
por: Echols, Melvin R, et al.
Publicado: (2006) -
Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis
por: Mavrakanas, Thomas A., et al.
Publicado: (2022) -
Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and
Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection
Fraction
por: Golwala, Harsh B., et al.
Publicado: (2013) -
Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction
por: Zamani, Payman, et al.
Publicado: (2017) -
Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure
por: Ofili, Elizabeth, et al.
Publicado: (2017)